$HR

Healthcare Realty (HR) Earnings Call Transcript

Image source: The Motley Fool.Friday, Oct. 31, 2025, at 9 a.m. ETHealthcare Realty Trust ( NYSE:HR ) reported $500 million in year-to-date dispositions as of fiscal Q3 2025 ( period ended Sept. 30, 2025 ) , with the remaining $700 million disposition pipeline primarily under binding agreement, ...

Original reporting
Motley Fool · https://www.facebook.com/themotleyfool/, Motley Fool Transcribing
Published Nov 2, 2025, 8:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 3, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Healthcare Realty (HR) Earnings Call Transcript — source image
Decision brief

The 30-second read

$HRNeutralMed
01

Why it matters

The asset sales could lead to short-term stock price adjustments but may improve financial flexibility.

02

Market read

The news is moderately relevant for investors in healthcare REITs and related sectors.

03

What to watch

Reinvestment plans and overall market conditions could mitigate negative impacts of asset sales.

Timing: Immediate, as earnings call provides recent insights.

Background

Healthcare Realty Trust has been actively managing its portfolio, with recent asset dispositions indicating a strategic repositioning.

Company-level read

Ticker impact

$HRNeutralMedium confidence
Context

Primary focus of the earnings call transcript, indicating direct relevance to Healthcare Realty Trust's stock performance.

Expected impact

Potential short-term decline due to asset sales, but long-term effects depend on reinvestment strategies.

Evidence & confidence

The reported dispositions suggest a strategic shift, but lack of detailed financials limits precise impact assessment.

Market effects

The real estate and healthcare sectors may experience volatility depending on investor perception of asset sales.

Limited, as the news pertains primarily to US-based assets.

Low, as the focus is on a specific REIT company.

Counterpoint

Asset dispositions may signal a proactive strategy to optimize portfolio, potentially leading to future growth.

Key entities

  • Healthcare Realty Trust

    A real estate investment trust focused on healthcare properties.

Related articles

$HRMedAI 8/10

Healthcare Realty Trust (HR) Q2 2026 Earnings Call Transcript

Healthcare Realty Trust (HR) reported Q2 2026 normalized FFO of $0.41/share and same-store cash NOI growth of 5.1% y/y. It raised normalized FFO guidance to $1.62 to $1.66/share and same-store cash NOI growth guidance to 4.3% to 5.0%. GAAP net loss was $0.13/share after $42.7m impairments. HR also discussed $200m JV acquisitions, $83m asset dispositions, and $75m Q2 repurchases.

$HRMed

Healthcare Realty Trust: Q2 Earnings Snapshot

Healthcare Realty Trust (HR) reported Q2 funds from operations of $143.7 million, or 41 cents per share, beating a Zacks-surveyed analyst average of 40 cents. The company posted a Q2 loss of $43.5 million, or 13 cents per share, and revenue of $281.8 million. Full-year FFO guidance is $1.62 to $1.66 per share.

$HRHigh

Healthcare Realty Trust Inc (HR): Results of Operations and Financial Condition

Healthcare Realty Trust Inc (HR) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release HEALTHCARE REALTY REPORTS SECOND QUARTER 2026 RESULTS AND FURTHER INCREASES FULL YEAR 2026 GUIDANCE NASHVILLE, Tennessee, July 30, 2026. Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2026. I n addition, t

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi